Related Experiment Video
Updated: Dec 10, 2025

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
Antimicrobial resistance modulation of MDR E. coli by antibiotic coated ZnO nanoparticles
Muhammad Ahsan Anwar1, Amjad Islam Aqib2, Khurram Ashfaq1
1Department of Clinical Medicine and Surgery, University of Agriculture, Faisalabad, 38000, Pakistan.
Abstract:
We evaluated three types of total six preparations against multidrug resistant E. coli i) three antibiotic coated ZnO nanoparticles (gentamicin coated nanoparticle-GNp; chloramphenicol coated nanoparticles-CNp; and both gentamicin & chloramphenicol coated nanoparticle-GCNp), ii) ZnO nanoparticle alone-Np, and iii) two antibiotics used in single (Gentamicin-G; and Chloramphenicol-C). A total of n = 200 sub-clinically positive mastitic milk samples of bovine origin were processed for isolation of MDR E. coli using microbiological and clinical laboratory & standard institute's protocols. ZnO Nps were prepared from zinc acetate dihydrate (Zn (CH3COO)2. 2H2O), polyethylene glycol (C2nH4n+2On+1), and urea (CH₄N₂O) by standard chemical protocol. Nps were characterized by XRD and STEM analyses while coating of antibiotics on Nps was confirmed by UV-Visible spectrophotometric analysis. Analysis of variance and student t-test were applied at 5% probability using SPSS version 22 statistical software for inferences on obtained data. There was significantly (p < 0.05) lowest minimum inhibitory concentrations (MICs) and highest zone of inhibitions (ZOIs) in case of GCNp (10.42 ± 4.51 μg/mL & 22.00 ± 1.00 mm) followed by GNp (20.79 ± 8.95 μg/mL & 20.00 ± 1.00 mm) and then CNp (25.96 ± 8.95 μg/mL & 12.33 ± 0.57 mm). Percentage increase in ZOI were expressed as 135.8, 78.43, and 312.76% by GCNp when compared with that of G, C, and Np, respectively. GNp and CNp coated preparations exhibited 114.36 and 275.73% increase in ZOI than to that of G and C, respectively. Similar trend was found in percentage reduction of MICs of preparations. Highest filamentation, indicator of bacterial damage, of E. coli was noted at MIC of GCNp followed by GNp and CNp. The study concluded antibiotic coated ZnO nanoparticles significant candidates modulating antibiotic resistance in MDR E. coli.
Insights
Antibiotic-coated zinc oxide nanoparticles (ZnO NPs) effectively combat multidrug-resistant E. coli. The combination of gentamicin and chloramphenicol on ZnO NPs demonstrated superior antimicrobial activity, offering a promising strategy against resistant bacterial infections.
Area of Science:
- Nanotechnology
- Microbiology
- Veterinary Medicine
Background:
- Multidrug-resistant (MDR) E. coli poses a significant threat in bovine mastitis.
- Conventional antibiotics are becoming less effective against MDR bacterial strains.
- Novel strategies are needed to overcome antibiotic resistance.
Purpose of the Study:
- To evaluate the efficacy of antibiotic-coated zinc oxide nanoparticles (ZnO NPs) against MDR E. coli.
- To compare the antimicrobial activity of different antibiotic-coated ZnO NP formulations with individual antibiotics and bare ZnO NPs.
- To assess the potential of these nano-formulations in combating antibiotic resistance.
Main Methods:
- Isolation and identification of MDR E. coli from bovine mastitic milk samples.
- Synthesis and characterization of ZnO NPs and antibiotic-coated ZnO NPs (gentamicin-coated nanoparticle-GNp, chloramphenicol-coated nanoparticle-CNp, and gentamicin & chloramphenicol-coated nanoparticle-GCNp).
- Determination of minimum inhibitory concentrations (MICs) and zone of inhibitions (ZOIs) for all preparations.
Main Results:
- GCNp exhibited the lowest MICs and highest ZOIs, indicating superior efficacy against MDR E. coli.
- Antibiotic-coated ZnO NPs showed significantly enhanced antimicrobial activity compared to individual antibiotics and bare ZnO NPs.
- Highest bacterial filamentation, indicative of cell damage, was observed with GCNp.
Conclusions:
- Antibiotic-coated ZnO NPs, particularly GCNp, are effective in modulating antibiotic resistance in MDR E. coli.
- These nano-formulations represent promising therapeutic candidates for treating MDR bacterial infections.
- The study highlights the potential of nanotechnology in addressing the challenge of antimicrobial resistance.
Related Concept Videos
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing

